Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

• Main Authors: Anjay Rastogi (Author), Ashté Collins (Author), Ellie Kelepouris (Author), Wayne Kotzker (Author), John P. Middleton (Author), Minesh Rajpal (Author), Prabir Roy-Chaudhury (Author), Glenn M. Chertow (Author)
• Format: Book
• Published: SAGE Publishing, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co-transporter-2 (SGLT2) inhibitor use in patients w...